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Abstract 
Background: Designing an appropriate data system is important to the success of a clinical study. However, little 
information is available on this topic. We share our experiences on designing, developing, and implementation of a 
data system for management of data and field activities of a complex clinical study.
Methods: The data system was implemented aiming at determining the biological basis for the underperformance 
of oral vaccines, such as polio and rotavirus vaccines in children at a site in Kolkata, India. The system included several 
functionalities to control data and field activities. It was restricted to authorized users based on their access privileges. 
A relational database platform was chosen, and Microsoft Visual FoxPro 7.0 (Microsoft Corporation, Seattle, WA, USA) 
was used to develop the system. The system was installed at the clinic and data office to facilitate both the field and 
data management activities.
Results: Data were doubly entered by two different data operators to identify keypunching errors in the data. Outli-
ers, duplication, inconsistencies, missing entries, and linkage were also checked. Every modification and users log-in/
log-out information was auto-recorded in an audit trail. The system offered tools for preparation of visit schedule of 
the participants. A visit considered as protocol deviation was documented by the system. The system alerted field 
staff to every upcoming visit date to organize the field activities and to inform participants which day to come. The 
system also produced a growth chart for evaluating nutritional status and referring the child to a specialized clinic if 
found to be severely malnourished.
Conclusion: The data system offered unique features for controlling for both data and field activities, which led to 
minimize drop-out rates as well as protocol deviations. Such system is warranted for a successful clinical study.
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Background
Clinical studies play important role for improving human 
health; therefore, these studies should be managed prop-
erly and carefully [1, 2]. Data collection, data cleaning, 
editing, and management of the data in compliance with 
regulatory standard and the International Conference 
on Harmonization Harmonized Tripartite Guideline for 
Good Clinical Practice (ICH GCP) are important aspects 
of a clinical study. A data system should ensure that these 
issues are well addressed in the system design [3]. The 
design should also ensure that the data are accurate, com-
plete and compliant with regulatory standards and GCP 
requirements, and the analyses are done using cleaned 
data sets. Besides, the system should include tools for 
providing support to the clinic, field and laboratory staff 
in order to collect data accurately and in a timely man-
ner. Only a few trials goes exactly as initially planned. For 
instance, a case report form (CRF) may need updating in 
Open Access
BMC Research Notes
*Correspondence:  drkim@ivi.int 
1 International Vaccine Institute, Seoul, South Korea
Full list of author information is available at the end of the article
Page 2 of 11Park et al. BMC Res Notes  (2016) 9:20 
the course of trial, a new trial site may be added, and new 
technology may emerge [4]. An investigator is, therefore, 
to worry about installing a data management system 
that is flexible and compliance with set guidelines and 
standards.
Although literature is plentiful in describing vari-
ous aspects of data analysis, little can be found that tells 
about practical aspects of designing a data system [5–8]. 
Rarely, a data system includes tools to perform both data 
and field activities. It is worth mentioning, analyses of 
the clinical studies can be flawed not only by problems in 
data acquisition and field methodology, but also by errors 
in the design of the data system.
Recent hardware and advanced software tools have 
made it possible to develop an ideal data system for clini-
cal studies [5]. In designing the system, one should con-
sider study objectives, nature of the study site, and the 
local issues. The design should be flexible to accommo-
date unanticipated issues in the field and data manage-
ment. Inclusions of tools for checking data outliers and 
inconsistencies as well as for queries are essential. Storing 
other information such as metadata (data dictionary) and 
audit trail, that tracks all the modifications ever made 
in the system, must be included in the system. While 
designing, one should also focus on system specifica-
tions, structure of the database, data and field manage-
ment tools, and performance of the system.
We designed, developed, and implemented a data sys-
tem for a complex clinical study in Kolkata, India. In the 
study, the vaccines was given to the participants concom-
itantly with the EPI routine immunization program for a 
period of 1 year, and there were multiple visits for speci-
men collection from the study participants, which could 
have been well managed with the support from the data 
system. This paper discusses the design, development, 




The clinical study named provide (Performance of Rota-
virus and Oral Polio Vaccine in Developing Countries) 
was initiated in Kolkata, India with the hypothesis that 
there are factors for the underperformance of oral vac-
cines in children living in the developing world. It aimed 
to determine whether decreased vaccine responsiveness 
to oral poliovirus or rotavirus vaccines is associated with 
the presence of tropical enteropathy (TE); and to evalu-
ate whether the impact of an inactivated polio vaccine 
(IPV) boosted systemic and mucosal immune responses 
to polio vaccines following vaccination with oral polio 
vaccine (OPV) in children with and without TE. The 
study was carried out among infants residing in Kolkata. 
The study aim was to recruit 372 children at 6 weeks of 
age and follow them until they were 53–54 weeks of age. 
There were 12 visits for each of the participants during 
the follow-up time including the initial visit. This study 
was also carried out in accordance with the routine 
immunization schedule in India. Therefore the partici-
pants would have to be vaccinated with other vaccines, 
such as, BCG, DPT, HepB and Measles.
The data system
A custom-made data system, named INDSys, was 
designed and developed aiming to turn the information 
from the participants into data, to transcribe the data into 
a database without errors, and to manage data delivery 
from clinics and laboratory efficiently. The design phase 
focused on defining the database components and the 
modules and interfaces required for satisfying the need of 
data and field activities. While developing the system, pro-
visions were kept for accommodating any new data or field 
related issues into the system. The system was developed 
using Microsoft Visual FoxPro 7.0 (Microsoft Corporation, 
Seattle, WA, USA), and the data was managed in a rela-
tional database environment. All related data, including 
clinical, laboratory and other data sets as well as field work 
schedule, were integrated within the data system.
The data system was restricted to authorized users only 
such as data managers, data operators, clinical monitors 
and investigators. There were two levels of restrictions 
in the system. At the first level, the users required log-
in identification and password to access the system. At 
the 2nd level, the system functionalities were restricted 
according to the user’s privileges. The functionalities 
according to the user’s role are shown in Table 1. The data 
entry screens were designed to look similar to the data 
forms for facilitating the data entry operations. A dual 
data entry system was designed to avoid keypunching 
errors in the data [9]. A comprehensive data validation 
tool was incorporated in order to identify missing values, 
outliers, duplications, and intra- and inter-record incon-
sistencies in the data. Errors that cannot be corrected, 
such as unordinary data or missing laboratory results in 
the system, were also selected to remain in the database 
with proper documentation. The data system automati-
cally stored information on changes in the data, users’ 
log-in, log-out, entry, modification, and deletion of the 
data in an audit trail. Information such as who changed 
the data and when the changes were made were also 
stored in the audit trail. Additional information such as a 
data dictionary, data status, data checking plan and code 
plans for open-ended questions were accessible through 
the system. A report generation module was included in 
the system to monitor the performance of field and data 
activities.
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For the field management, the system design included 
activities in field office, such as participant’s contact, 
calendar of all visits, participant’s discontinuation/
drop-outs, growth chart, missing visits, etc. Necessary 
tools (vide infra) were included in the system so that the 
field management could control the activities easily and 
smoothly, especially for this complicated schedule of vis-
its. Each participant was to be vaccinated with several 
vaccines (e.g. DPT, HepB, and Oral Polio Vaccine) in 
accordance with Expanded Program on Immunization 
(EPI) in India, and study vaccines (e.g., Rotavirus, Oral 
Polio Vaccine, or Inactivated Polio Vaccine). If a partici-
pant received a vaccine on a day other than the scheduled 
day, the subsequent date of vaccination as well as sched-
uled dates of visit for specimen collection would also 
change to the date of vaccination and a new calendar for 
the visitation schedule was prepared for the participant 
accordingly. The data system included tools to generate 
the new visitation schedule after each visit was made by 
a participant.
Implementation of the data system
The data system was implemented in standalone comput-
ers at the data center and at the field clinic of the National 
Institute for Cholera and Enteric Disease (NICED). 
Microsoft Windows was chosen as the operating system 
to implement the data system. No other software was 
required to operate the system. The data and field staff of 
the project were trained on how to operate the data sys-
tem. Authorized users, had access to the system through 
assigned identification and password. The staff members 
at the clinic had access to the system only for manage-
ment of the field activities. The database at the clinic was 
continuously updated by the data staff of the project to 
facilitate field activities with updated data sets.
Ethical considerations
Written informed consent was obtained by moth-
ers of participating children. The study protocol was 
approved by the scientific advisory committee (SAC), 
Institutional Ethics Committee of the National Institute 
of Cholera and Enteric Diseases (NICED), the Health 
Ministry Screening Committee of India, and the Inter-
national Vaccine Institute Institutional Review Board. 
The protocol was registered at clinical trial registry of 




Upon starting the system, a log-in screen appears for 
accessing the system. After successful log-in, a menu 
describing the list of activities appears on the screen 
according to the user’s privileges. As a dual data entry 
system, the system provides options for entering the 
data either in the 1st or 2nd file according to the user’s 
privileges. If the operator enters a Screening Number 
for a new recruitment, the system shows the Data Entry 
Status screen (called start-up screen) of the participant 
(Fig. 1). In this screen, the data entry status for the dif-
ferent visits of the participant is reflected by color, and 
the number of successful and missed visits are easily 
identifiable. Since the screening form is used to assign 
the Study ID, the user will receive an error message if 
s/he tries to enter any other forms before entering the 
screening form. In the event of early termination of a 
participant, the operators are not allowed to enter any 
other forms of the participant. When one-year of follow-
up of a participant is passed, the system checks for miss-
ing visits and specimens, and alerts accordingly. This 
helps ensure completeness of the data entries of all visits 
of a participant.
Data entry and editing
The study had two sources of data: clinic and lab. The 
data from the clinic, such as enrolment, follow-up, and 
specimen collection were entered into the data system 
soon after receiving the forms. The lab data were entered 
and verified by lab scientists following data validation 
rules and then uploaded onto the system. The embedded 
data validation process in the system ensures quality of 
the data after checking for outliers and inconsistencies.
Table 1 Accessible functionalities according to the user’s role
Role Main responsibilities Accessible functionalities
Database administrator Grant permission to a user for accessing system and maintain 
system and troubleshooting
All functions
Data manager Supervise data entry, error check, and backup Entry, view/edit/delete, dual check, error check, report/query, 
maintenance(backup, change password)
Data operators Data entry and check dual entry error Entry, view/edit, dual check, maintenance (change password)
Clinical monitor(s) View data for monitoring electronic data View, report/query, maintenance (change password)
Investigator(s) Supervise all data activities View, report/query, maintenance (change password)
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While entering the data from the clinic, the other 
functions are inactivated by the system. In the event of 
a potential error during data entry, the system warns the 
operator and provides options for correcting it. However, 
the operator can move on without correcting the data if 
the correction cannot be made at his/her level. A specific 
module for data checking is incorporated into the system 
(vide supra) to trap any error in the database.
The system provides a view screen for reviewing all data 
forms in one screen. The user can view the data by using 
navigation keys located on the right side of the page of 
the screen and selecting the participant ID, or by entering 
the participant ID in a specified box. If a participant ID 
is selected, the participant’s data form can be viewed by 
clicking on a specific tab of the form abbreviations.
The lab data, before final submission to data room, 
were recorded on specific data forms designed for lab 
results, dually entered in Excel, and further checked by 
lab personals. The data generated by the laboratory is 
uploaded onto the system from the soft copy of the data. 
In this case, the user clicks onto the Upload Lab Result 
tool to get the list of the file names of all the lab data. If 
a wrong file name is selected, the system warns the user 
and prevents him/her from uploading the data.
Unlike clinic data, the lab data are not allowed to edit 
directly on the screen. If an error is detected in the lab 
data, the error is sent to the laboratory for correction. 
After getting the corrected data in a soft copy, the erro-
neous data was replaced with the corrected one.
Data validation and audit trail
There were two modules in the system for checking 
accuracy of the data. Firstly, the data are doubly entered 
to detect keypunching errors. The system provides a 
list of discrepancies between the two entries including 
unmatched unique identification of the children between 
the two entries. Once the keypunching errors in the data 
are resolved, the user is allowed to move to the second 
step of data checking which includes outliers, inconsist-
encies, validity of the dates, and linkage. If the errors 
generated at the source, the forms along with the type 
of errors are sent to the field office for resolution. Once 
the error feedbacks are received, the data are updated 
accordingly. When an update is done, the user ID, date 
and time of update, and old and new values are stored 
in the audit trail. Audit trails are being created incre-
mentally, in chronological order, and in a manner that it 
does not allow new audit trail information to overwrite 
Fig. 1 The status of data entries of the different forms of a participant (start-up screen)
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existing data. If updates are made multiple times, the 
users can trace complete history of the updates.
Producing schedule of visits
As mentioned above, there were 12 visits for each partici-
pant in a year including the initial visit for consent and 
screening of the participants. It was necessary to cal-
culate the scheduled dates of visit for each participant 
during the follow-up period, and remind them to come 
to the clinic on that date. Since enrolment dates differed 
from one participant to another and the purpose of visit 
also differed from one visit to another, keeping track of 
the schedule dates and purpose of visit would be difficult 
without having field management tools in the system. 
Note that the scheduled dates of visit might also change 
depending on the last date of visit. The system pro-
duces a fresh calendar of the scheduled dates of appoint-
ments after every visit is made (Fig. 2). This helped Field 
Supervisors to fill the dates of visit schedule in the Study 
Identification Card which should be brought when the 
participants come to the clinic, to remind them by tel-
ephone and home visit prior to the schedule date, and 
to identify whether the visits were made on the planned 
date or not. The system also produces the list of all visits 
to be made on the upcoming clinic day (an example is 
shown in Fig. 3), so that the field staff can take necessary 
actions to make those visits successful.
Data backup
Data can be lost by a computer accident or catastrophic 
loss -such as losing a critical file or experiencing unex-
plained file corruption, a hard drive crash, or total sys-
tem loss. The system provides a backup tool to maintain a 
regular backup at the end of each working day. A backup 
copy was kept in a separate building away from the data 
center.
Reporting protocol deviation
One of the most challenging tasks of the clinical study 
was to manage the scheduled dates of visits of the par-
ticipants for vaccination and specimen collection. The 
target visit dates may change depending on the previ-
ous date of visit of the participants. For visit week 6–18, 
participants will be invited to come to the clinic based 
on the date of his/her last vaccination on account of the 
mandatory 4  weeks window between vaccinations. For 
visit week 24–53, participants will be at age of the visit 
week +7 days, regardless of the date of last vaccination. 
Fig. 2 The schedule of visit dates at the clinic of a participant
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If a visit or procedure cannot be made within the specific 
time period (called window period), then those visits or 
procedures are treated as protocol deviation. Since this 
clinical study depends largely on the biological issues, 
any protocol deviation would have negative impact on 
the results of the analysis. Therefore, it was important to 
keep the number of protocol deviations as minimized as 
possible.
The data system produces how many visits or proce-
dures turned out to be protocol deviation. Note that the 
system generated protocol deviation is data driven, thus 
the study could overcome limitation of manually created 
protocol deviation form, which is prone to error and may 
differ from the data actually stored in the database. An 
example of the system generated protocol deviation is 
shown in Fig. 4. The system also provides the status of all 
visits, vaccinations, and sample collections with (in red 
color) and without (in green color) protocol deviation 
(Fig. 5).
Reporting of severely malnourished children
The study required referring severely malnourished 
children to a specialized clinic for treatment. Upon 
request, the system provides an anthropometric data 
calculator for calculating nutritional status and draw-
ing growth charts of the children, which were evaluated 
to understand the nutritional status of the children. The 
system produces two types of growth chart for each par-
ticipant: weight-for-age and length-for-age. By triggering 
the participant’s ID, the user can instantly get the child’s 
growth status according to the World Health Organiza-
tion (WHO) child growth standard (http://www.who.
int/childgrowth/standards), as shown in Fig. 6. In the fig-
ure, the two lines from the bottom were related to mal-
nutrition status. If the child’s weight or height is marked 
below the line of SD2neg (<-2SD), the child is considered 
malnourished. If the child’s weight or height is marked 
between line of SD2neg and SD3neg, the child is consid-
ered moderate malnourished. And, if the child’s weight 
or height is marked below SD3neg (<-3SD), the child is 
considered severely malnourished. In case of severely 
malnourished, the child was referred to a specialized 
clinic for treatment. However, with this growth chart, the 
user could not get z-scores for anthropometric indicators 
(weight-for-age and height-for-age) based on the WHO 
child growth standard. Thus, the list of severely malnour-
ished children generated from the system was just to 
facilitate field activities (Figs. 7, 8).
Discussion
Running a clinical study smoothly like ours is challeng-
ing due to its complex and long duration visit schedule. 
Fig. 3 List of the participants to be visited on the upcoming clinic day
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In our study, all 372 participants were successfully 
recruited according to the planned schedule. The drop-
out rates were only 8 % and protocol deviations stood at 
3 %. The reasons for these protocol deviations included: 
visits occurring outside the window period (44 %), missed 
specimen (34 %), missed visits (11 %), specimen collected 
outside the window period (10  %), and missed proce-
dures (1 %). 99 % blood samples, 95 % stool samples, 98 % 
Fig. 4 A protocol deviation form generated from the data system
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urine samples, and 100 % breast milk samples were suc-
cessfully collected. Such an excellent performance would 
have not been possible without having the support pro-
vided by the data system.
In addition to manage data activities and generate 
data reports, our data system provides support for man-
agement of the field activities such as preparing visit 
schedule, alerting next day visit schedule and assess-
ing requirement of the logistics including number of 
doses of the vaccines, etc. for the next visit schedule. It 
also ensures a good clinical practice, a legal requirement 
to conduct clinical trials in many countries. The other 
advantage in our system is that it generates nutritional 
status report of the participants at each time point so as 
to take immediate actions against severely malnourished 
infants, such as referring to a specialized clinic where 
proper treatment can be ensured. In the system, the 
data interoperabilities are limited to Acrobat Reader and 
Excel, as required by us. However, we have kept provision 
for the data interoperability in any other standard data 
format.
Our data system is specific to our study, which is 
unlikely to match exactly with any other studies. Three-
month time of a skilled system designer and programmer 
was required to design and develop the system. Unlike 
open source software where many developers have the 
opportunity to scrutinize the system, our system was 
scrutinized in-house.
Since many developers scrutinized the open source 
application, it is hard for bugs to hide in that application. 
Also, since codes of the open source software are shared 
among numerous parties, it is typically well structured, 
which cannot be ensured a single company develops like 
us [10].
However, our system passes through different courses 
of action over the time, and we were able to fix the bugs 
in the system. More importantly, we were able to tailor it 
specific to the project activities, which may not have been 
possible in an open source software solution.
The limitation in our system is that it was installed 
on standalone computers. Therefore, we had to upload 
of the updated database to the field office computer on 
a regular basis. Similarly, the data generated at the lab 
were uploaded manually into the system. This offline 
mechanism could have been avoided if the computers 
at the clinic and lab were connected to the data office 
through a network. However, we could not make it pos-
sible in our setting due to limitation of resources.
Still a large part of clinical centers uses their own 
developed solution or a single solution [11] because 
Fig. 5 The status of visits and vaccinations, and sample collections with protocol deviation status generated by the data system
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Fig. 6 A growth chart generated by the data system
Fig. 7 An anthropometric calculator
Page 10 of 11Park et al. BMC Res Notes  (2016) 9:20 
clinical data managements are very heterogeneous, 
and the open source solutions do not play a major 
role in clinical trial data management [12]. However, 
because of flexibility, increased innovation, shorter 
development times, and faster procurement processes, 
open source software may be attracted by an organi-
zation. Also by using open source software, an organi-
zation will not be locked into using a proprietary 
software program. One disadvantage in an open source 
solution is that, due to the web-based nature of this 
system, it may pose a challenge for real time data entry 
because in many developing country settings internet 
connectivity is a problem. One may also face slug-
gish response times and system timeouts. Addition-
ally, XML rules may adversely affect the application’s 
response time and therefore other options may need to 
be explored and used while using open software solu-
tion [3].
Conclusion
Clinical data management has evolved and will continue 
to do so in response to need [13]. Limited literature hin-
ders the capacity of scientists to design and develop a 
well-managed data system for their studies [14]. An ill-
managed data system may lead to false outcomes, which 
is detrimental for the study; eventually for human health. 
The concepts and ideas we discussed in this paper may 
be useful for designing and developing a well-managed 
data system for the clinical studies. By controlling both 
the data and field activities in a system, the investigators 
may overcome the complexities of the visit schedules in 
their studies. We believe such a system would be useful 
for the investigators who want to initiate a complex clini-
cal study.
Availability of supporting data
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upon request.
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